Previous studies have demonstrated that the chemokine CXCL10 plays a key role in the recruitment of CD8 + T cells to tumor sites, and increased CXCL10 levels are associated with increased tumor infiltration of CD8 + T cells and tumor clearance or regression [61–63]. This evidence concerns the gene CXCL10 and neoplasm.